Having trouble finding a Sector – Health fund? Janus Henderson Global Life Science T (JAGLX) is a potential starting point. JAGLX bears a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance.
Objective
The world of Sector – Health funds is an area filled with options, such as JAGLX. Healthcare is one of the biggest sectors of the American economy, and Sector – Health mutual funds provide a great opportunity to invest in this industry. Here, funds can include everything from for-profit hospitals to pharmaceutical companies and medical device manufacturers.
History of Fund/Manager
JAGLX finds itself in the Janus Fund family, based out of Boston, MA. Janus Henderson Global Life Science T debuted in December of 1998. Since then, JAGLX has accumulated assets of about $1.35 billion, according to the most recently available information. The fund’s current manager, Andrew Acker, has been in charge of the fund since May of 2007.
Performance
Investors naturally seek funds with strong performance. JAGLX has a 5-year annualized total return of 8.29%, and is in the top third among its category peers. If you’re interested in shorter time frames, do not dismiss looking at the fund’s 3-year annualized total return of 12.81%, which places it in the top third during this time-frame.
It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower.
When looking at a fund’s performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. JAGLX’s standard deviation over the past three years is 15.83% compared to the category average of 11.74%. Looking at the past 5 years, the fund’s standard deviation is 15.71% compared to the category average of 13.41%. This makes the fund more volatile than its peers over the past half-decade.
Risk Factors
Investors should note that the fund has a 5-year beta of 0.61, which means it is hypothetically less volatile than the market at large. Another factor to consider is alpha, as it reflects a portfolio’s performance on a risk-adjusted basis relative to a benchmark-in this case, the S&P 500. JAGLX has generated a negative alpha over the past five years of -0.68, demonstrating that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.